Ga direct naar

Cinderella Therapeutics: a not-for-profit organization seeking to develop stepchild drugs and therapies.

Welcome to Cinderella Therapeutics

Cinderella Therapeutics Foundation is a first in the Netherlands, and possibly in the world: a not-for-profit organization seeking to develop new drugs or therapies for patients at an affordable price. Cinderella focuses exclusively on promising therapies ignored by commercial enterprises due to their poor potential for generating revenues. Cinderella calls such inventions 'stepchild' drugs or therapies. The founders of Cinderella believe that stepchild therapies can be revived and brought to rapid clinical applications by abandoning the profit principle and by selecting promising projects. Each study is directed by physician/scientists and focused on patients. Participants are scientists at selected academic centers and philanthropists willing to provide both working capital and their talents.

The start of Cinderella received extensive attention from the media late 2010. In a few months time, we received hundreds of expressions of sympathy including declarations of support and assistance in various forms. In addition, there were many nominations of potential stepchild drugs. After thorough examination a dozen of these is considered for further development. We will regularly report on this site on the progress made and the problems that arise. We hope to ensure that interested scientists and philanthropists collaborate with us, offer solutions and submit suggestions for new projects.


Cinderella safeguards continued access to study medication after discontinuation of clinical trials.

Wednesday 06 August 2014 14:43 Cinderella’s recommendation of a formal agreement on continued access to study medication after discontinuation of clinical trials has been endorsed by the Board of the Association of Medical Ethical Committees in the Netherlands. full story

Dutch pharmacist is a historical thorn in the side of the pharmaceutical industry

Wednesday 16 July 2014 21:43 In a recent contribution to the Dutch Pharmaceutisch Weekblad our board member professor Toine Pieters urges policy makers, politicians and judges to keep in mind that the preparation of medicines to an individual standard is indispensable for maintaining high standards of pharmaceutical care. full story

Tapering paroxetine better and safer with taperingstrip

Monday 30 December 2013 14:10 The first taperingstrip for paroxetine is now available for patients in the Netherlands. With this strip it will be possible to taper off paroxetine better and safer than with the current standard... full story

Ataluren project completed.

Friday 10 August 2012 14:39 The patients are receiving their medication again. Read about the court case, the reactions and our request for donations. full story

Subscribe to eAlert